Katherine Ann Rubino
April 9, 2020
COVID-19: HOW THE UNITED STATES PATENT AND TRADEMARK OFFICE IS IMPACTED BY THE CORONAVIRUS PANDEMIC By: Katie Rubino Recently, the United States Patent and Trademark Office […]
March 26, 2020
CORONAVIRUS CATASTROPHE: THE VALUE OF INTELLECTUAL PROPERTY DURING AN ECONOMIC DOWNTURN By: Katie Rubino As the number of cases of the novel coronavirus around the world […]
October 7, 2019
CAFC TO HEAR MEDTECH PATENT DISPUTE BETWEEN 23ANDME, INC. V. ANCESTRY.COM DNA, LLC By: Katie Rubino On October 2nd, 2019 oral arguments commenced at […]
July 29, 2019
CAFC Rules Suboxone Patent is Not Infringed by Generic Buprenorphine Film Product By: Katie Rubino Recently on July 9th the Court of Appeals for […]
July 8, 2019
Patent Strategies for Small Molecule Drugs Versus Biological Drugs By: Katie Rubino Molecules used as drug products are often categorized into two classes: small […]
June 11, 2019
CAFC Affirms Invalidation of Oxycodone Patent for Lack of Written Description By: Katie Rubino On April 19th, 2019 the Court of Appeals of the Federal […]
May 28, 2019
Supreme Court Denies Certiorari Petition on Tribal Sovereign Immunity in IPR Proceedings By: Katie Rubino Recently at the end of April, the Supreme Court denied […]
May 6, 2019
CAFC Affirms Nonobviousness of Vitamin B12 and Folate Administration Prior to Chemotherapy By: Katie Rubino On April 26, 2019, the Court of Appeals for the […]
April 22, 2019
IPR Incomplete: PTAB Fails to Initiate Indefinite IPR Petition By: Katie Rubino Recently on March 6, 2019 the Patent Trial and Appeal Board (PTAB) issued […]
April 8, 2019
PTAB Enacts New Pilot Program on Motions to Amend During Post Grant Proceedings By: Katie Rubino Recently the Patent Trial and Appeal Board (PTAB) instituted […]